A detailed history of Meridian Wealth Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Meridian Wealth Management, LLC holds 82,840 shares of NUVB stock, worth $213,727. This represents 0.01% of its overall portfolio holdings.

Number of Shares
82,840
Previous 56,345 47.02%
Holding current value
$213,727
Previous $164,000 15.85%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.3 - $3.83 $60,938 - $101,475
26,495 Added 47.02%
82,840 $190,000
Q2 2024

Aug 08, 2024

BUY
$2.58 - $3.69 $145,370 - $207,913
56,345 New
56,345 $164,000
Q3 2022

Nov 14, 2022

BUY
$0.29 - $4.04 $427 - $5,959
1,475 Added 14.22%
11,850 $27,000
Q2 2022

Aug 05, 2022

BUY
$3.24 - $5.85 $33,615 - $60,693
10,375 New
10,375 $34,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $560M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Meridian Wealth Management, LLC Portfolio

Follow Meridian Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Wealth Management, LLC with notifications on news.